Table 4.
Association between OVF and age, AMH baseline level and chemotherapy treatment (Chi-square tests)
| Without OVF No (%) | With OVF No (%) | P value | |
|---|---|---|---|
| Overall | 0.002 | ||
| Age<40 | 22(55%) | 18(45%) | |
| Age>=40 | 6(17.6%) | 28(82.4%) | |
| Over all AMH | 0.018 | ||
| Baseline<1.1ng/ml | 4(17.4%) | 19(82.6%) | |
| Baseline>1.1 ng/ml | 24(49.0%) | 25(51.0%) | |
| Endocrine therapy | 0.174 | ||
| Without | 10(40%) | 15(60%) | |
| With | 11(22.9%) | 37(77.1%) | |
| GnRHa | 0.002 | ||
| Without | 7(19.4%) | 29(80.6%) | |
| With | 21(55.3%) | 17(44.7%) |
Chemo denotes chemotherapy.